Anthrax News and Research

RSS
Anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in wild and domestic lower vertebrates (cattle, sheep, goats, camels, antelopes, and other herbivores), but it can also occur in humans when they are exposed to infected animals or tissue from infected animals.

Anthrax is most common in agricultural regions where it occurs in animals. These include South and Central America, Southern and Eastern Europe, Asia, Africa, the Caribbean, and the Middle East. When anthrax affects humans, it is usually due to an occupational exposure to infected animals or their products. Workers who are exposed to dead animals and animal products from other countries where anthrax is more common may become infected with B. anthracis (industrial anthrax). Anthrax outbreaks occur in the United States on an annual basis in livestock and wild game animals such as deer.

Anthrax infection can occur in three forms: cutaneous (skin), inhalation, and gastrointestinal. B. anthracis spores can live in the soil for many years, and humans can become infected with anthrax by handling products from infected animals or by inhaling anthrax spores from contaminated animal products. Anthrax can also be spread by eating undercooked meat from infected animals. It is rare to find infected animals in the United States.
Pentagon too slow responding to Anthrax scare

Pentagon too slow responding to Anthrax scare

Antibodies from tobacco plants protect against anthrax

Antibodies from tobacco plants protect against anthrax

Fabric treated with an antimicrobial compound can kill dormant anthrax spores

Fabric treated with an antimicrobial compound can kill dormant anthrax spores

Anthrax scare due to lab mix up

Anthrax scare due to lab mix up

Anthrax scare in Pentagon false alarm

Anthrax scare in Pentagon false alarm

Search for Anthrax bacteria in Pentagon mail

Search for Anthrax bacteria in Pentagon mail

New immunotherapeutic approach against anthrax

New immunotherapeutic approach against anthrax

FDA approves new smallpox vaccination

FDA approves new smallpox vaccination

PAHO vaccines books wins major award

PAHO vaccines books wins major award

Home HIV-AIDS test could be a reality within two years

Home HIV-AIDS test could be a reality within two years

Gene transfer used to deliver antibodies to fight Anthrax

Gene transfer used to deliver antibodies to fight Anthrax

New portable infectious disease detector

New portable infectious disease detector

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Vaccine Treatment and Evaluation Units (VTEUs) supply the nurse power necessary to beat back or altogether prevent infectious disease

Study models impact of anthrax vaccine

Study models impact of anthrax vaccine

Alliance to develop and commercialize fully-human anti-anthrax antibody

Alliance to develop and commercialize fully-human anti-anthrax antibody

Oral administration of saline spray may stop spread of influenza, tuberculosis, and SARS

Oral administration of saline spray may stop spread of influenza, tuberculosis, and SARS

Animal research and its benefits to both humans and animals

Animal research and its benefits to both humans and animals

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

VaxGen gets $877.5 million to supply 75 million doses of anthrax vaccine

$73 million to tackle infectious diseases such as West Nile virus and influenza

$73 million to tackle infectious diseases such as West Nile virus and influenza

New vaccines to counter biological agents such as anthrax

New vaccines to counter biological agents such as anthrax